Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 238

1.

Investigation of potential mechanisms of sex differences in quinidine-induced torsade de pointes risk.

Vicente J, Simlund J, Johannesen L, Sundh F, Florian J, Ugander M, Wagner GS, Woosley RL, Strauss DG.

J Electrocardiol. 2015 Jul-Aug;48(4):533-8. doi: 10.1016/j.jelectrocard.2015.03.011. Epub 2015 Mar 12.

PMID:
25796102
2.

An interview with Raymond L. Woosley.

Woosley RL.

Trends Pharmacol Sci. 2014 Jul;35(7):305-7. doi: 10.1016/j.tips.2014.05.002. Epub 2014 Jun 6. No abstract available.

PMID:
24913995
3.

Assessing cardiovascular drug safety for clinical decision-making.

Woosley RL, Romero K.

Nat Rev Cardiol. 2013 Jun;10(6):330-7. doi: 10.1038/nrcardio.2013.57. Epub 2013 Apr 16. Review.

PMID:
23591268
4.

Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics.

Postema PG, Neville J, de Jong JS, Romero K, Wilde AA, Woosley RL.

Europace. 2013 Jul;15(7):1042-9. doi: 10.1093/europace/eut018. Epub 2013 Mar 26.

5.

It is important research, but why is it necessary?

Woosley RL.

Clin Pharmacol Ther. 2013 Apr;93(4):297-9. doi: 10.1038/clpt.2013.15.

PMID:
23511783
6.

Regulatory and reimbursement innovation.

Lindor RA, Allocco SJ, Cheatham L, Cortese DA, Hall RF, Mangold WJ Jr, Pizziconi V, Poste G, Quinn B, Roth M, Saks MJ, Wassman ER, Woosley RL, Marchant GE.

Sci Transl Med. 2013 Mar 13;5(176):176cm3. doi: 10.1126/scitranslmed.3005437.

PMID:
23486776
7.

One hundred years of drug regulation: where do we go from here?

Woosley RL.

Annu Rev Pharmacol Toxicol. 2013;53:255-73. doi: 10.1146/annurev-pharmtox-011112-140159. Epub 2012 Oct 16. Review.

PMID:
23072378
8.

Is it possible for FDA regulatory scientists and industry scientists to work together?

Woosley RL.

Clin Pharmacol Ther. 2012 Mar;91(3):390-2. doi: 10.1038/clpt.2011.304.

PMID:
22343817
9.

Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.

Hines LE, Ceron-Cabrera D, Romero K, Anthony M, Woosley RL, Armstrong EP, Malone DC.

Clin Ther. 2011 Jan;33(1):36-45. doi: 10.1016/j.clinthera.2011.01.021.

PMID:
21397772
10.

Community pharmacy and pharmacist staff call center: assessment of medication safety and effectiveness.

Higgins L, Brown M, Murphy JE, Malone DC, Armstrong EP, Woosley RL.

J Am Pharm Assoc (2003). 2011 Jan-Feb;51(1):82-9. doi: 10.1331/JAPhA.2011.09108.

PMID:
21247830
11.

Research at the interface of industry, academia and regulatory science.

Mattes WB, Walker EG, Abadie E, Sistare FD, Vonderscher J, Woodcock J, Woosley RL.

Nat Biotechnol. 2010 May;28(5):432-3. doi: 10.1038/nbt0510-432. No abstract available.

PMID:
20458309
12.

The Critical Path Institute's approach to precompetitive sharing and advancing regulatory science.

Woosley RL, Myers RT, Goodsaid F.

Clin Pharmacol Ther. 2010 May;87(5):530-3. doi: 10.1038/clpt.2010.27. Review.

PMID:
20407457
13.

The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases.

Romero K, de Mars M, Frank D, Anthony M, Neville J, Kirby L, Smith K, Woosley RL.

Clin Pharmacol Ther. 2009 Oct;86(4):365-7. doi: 10.1038/clpt.2009.165.

PMID:
19763117
14.

Time to replace Bazett's QT-correction.

Woosley RL, Romero K.

Pacing Clin Electrophysiol. 2009 Nov;32(11):1379-80. doi: 10.1111/j.1540-8159.2009.02513.x. Epub 2009 Aug 27. No abstract available.

PMID:
19712074
15.

Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.

Anthony M, Romero K, Malone DC, Hines LE, Higgins L, Woosley RL.

Clin Pharmacol Ther. 2009 Oct;86(4):425-9. doi: 10.1038/clpt.2009.95. Epub 2009 Jul 8.

PMID:
19587643
16.

Clarification to the www.qtdrugs.org updated lists.

Romero K, Woosley RL.

Pharmacoepidemiol Drug Saf. 2009 May;18(5):423-4. doi: 10.1002/pds.1727. No abstract available.

PMID:
19382150
17.

Potential determinants of prescribers' drug-drug interaction knowledge.

Ko Y, Malone DC, D'Agostino JV, Skrepnek GH, Armstrong EP, Brown M, Woosley RL.

Res Social Adm Pharm. 2008 Dec;4(4):355-66. doi: 10.1016/j.sapharm.2007.10.004. Epub 2008 Aug 8.

PMID:
19064242
18.

Pharmacokinetics of sertraline across pregnancy and postpartum.

Freeman MP, Nolan PE Jr, Davis MF, Anthony M, Fried K, Fankhauser M, Woosley RL, Moreno F.

J Clin Psychopharmacol. 2008 Dec;28(6):646-53. doi: 10.1097/JCP.0b013e31818d2048.

PMID:
19011433
19.

The translational path includes the FDA's critical path.

Woosley RL.

J Cardiovasc Transl Res. 2008 Sep;1(3):188-9. doi: 10.1007/s12265-008-9043-z. Epub 2008 Aug 11. No abstract available.

PMID:
20559915
20.

Gender and age differences in medications dispensed from a national chain drugstore.

Anthony M, Lee KY, Bertram CT, Abarca J, Rehfeld RA, Malone DC, Freeman M, Woosley RL.

J Womens Health (Larchmt). 2008 Jun;17(5):735-43. doi: 10.1089/jwh.2007.0731.

PMID:
18537477
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk